| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |